Prevalence and Associated Factors of Metabolic Syndrome Among Patients with Severe Mental Illness at Hawassa, Southern-Ethiopia

References

• Hansson L. Determinants of quality of life in people with severe mental illness. Acta Psychiatr Scand Suppl. 2006;429:46–50. doi:10.1111/j.1600-0447.2005.00717.x
   Google Scholar
• Talarowska M, Florkowski A, Orzechowska A, Zbolarski K, Wysokiński A. Konsekwencje psychologiczne zespołu metabolicznego. Psychiatria w Praktyce Klinicznej. 2008;1:67–73.
   Google Scholar
• Correll CU, Detraux J, De Lepeleire J, De Hert M. Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder. World Psychiatry. 2015;14:119. doi:10.1002/wps.v14.2
   PubMed Web of Science ®Google Scholar
• De Hert M, Dekker JM, Wood D, Kahl KG, Holt RI, Möller HJ. Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). Eur Psychiatry. 2009;24:412–424. doi:10.1016/j.eurpsy.2009.01.005
   PubMed Web of Science ®Google Scholar
• Carpiniello B, Pinna F, Velluzzi F, Loviselli A. Mental disorders in patients with metabolic syndrome. The key role of central obesity. Eat Weight Disord. 2012;17:e259–66.
   PubMedGoogle Scholar
• Alberti KG, Zimmet P, Shaw J. Metabolic syndrome- A new world-wide definition. A Consensus Statement from the international diabetes federation. Diabet Med. 2006;23:469–480.
   PubMed Web of Science ®Google Scholar
• De Hert M, Cohen D, Bobes J, et al. Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level. World Psychiatry. 2011;10:138–151. doi:10.1002/wps.2011.10.issue-2
   PubMed Web of Science ®Google Scholar
• Gopalaswamy AK, Morgan R. Too many chronic mentally disabled patients are too fat. Acta Psychiatr Scand. 1985;72:254–258. doi:10.1111/acp.1985.72.issue-3
   PubMed Web of Science ®Google Scholar
• Bressington DT, Mui J, Cheung EFC, Petch J, Clark AB, Gray R. The prevalence of metabolic syndrome amongst patients with severe mental illness in the community in Hong Kong–a cross sectional study. BMC Psychiatry. 2013;13:87. doi:10.1186/1471-244X-13-87
   PubMed Web of Science ®Google Scholar
• Ventriglio A, Gentile A, Stella E, Bellomo A. Metabolic issues in patients affected by schizophrenia: clinical characteristics and medical management. Front Neurosci. 2015;9:297–303. doi:10.3389/fnins.2015.00297
   PubMed Web of Science ®Google Scholar
• Lee J, Nurjono M, Wong A, Salim A. Prevalence of metabolic syndrome among patients with schizophrenia in Singapore. Ann Acad Med. 2012;41:457–462.
   PubMed Web of Science ®Google Scholar
• De Hert M, Detraux J, Vancampfort D. The intriguing relationship between coronary heart disease and mental disorders. Dialog Clin Neurosci. 2018;20:31–40.
   PubMedGoogle Scholar
• Rummel-Kluge C, Komossa K, Schwarz S, et al. Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis. Schizophr Res. 2010;123:225–233. doi:10.1016/j.schres.2010.07.012
   PubMed Web of Science ®Google Scholar
• Fonseka TM, Müller DJ, Kennedy SH. Inflammatory cytokines and antipsychotic-induced weight gain: review and clinical implications. Mol Neuropsychiatry. 2016;2:1.
   PubMedGoogle Scholar
• Takeuchi T, Nakao M, Nomura K, et al. Association of the metabolic syndrome with depression and anxiety in Japanese men: a 1-year cohort study. Diabetes Metab Res Rev. 2009;25:762–767. doi:10.1002/dmrr.1041
   PubMed Web of Science ®Google Scholar
• Osborn DP. The poor physical health of people with mental illness. West J Med. 2001;175:329–332. doi:10.1136/ewjm.175.5.329
   PubMedGoogle Scholar
• Latoo J, Mistry M, Dunne FJ. Physical morbidity and mortality in people with mental illness. BJMP. 2013;6:a621.
   Google Scholar
• Asaye S, Bekele S, Tolessa D, Cheneke W. Metabolic syndrome and associated factors among psychiatric patients in Jimma University Specialized Hospital, South West Ethiopia. Clin Res Rev. 2018;12:753–760.
   Google Scholar
• Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 2009;120:1640–1645. doi:10.1161/CIRCULATIONAHA.109.192644
   PubMed Web of Science ®Google Scholar
• Zimmet P, Alberti KGM, Serrano Ríos M. A New International Diabetes Federation (IDF) Worldwide definition of the metabolic syndrome: the rationale and the results. Rev Esp Cardiol. 2005;58:1371–1376.
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). Chronic diseases and health promotion: stepwise approach to surveillance (STEPS); 2010. Available from: http://www.who.int/chp/steps/manual/en/. Accessed February 19, 2020.
   Google Scholar
• Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Arch Intern Med. 1998;158:1855–1867. doi:10.1001/archinte.158.17.1855
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO Stepwise Approach to Surveillance (STEPS). Geneva: World Health Organization (WHO); 2008.
   Google Scholar
• Moreira FP, Jansen K, Cardoso TA, et al. Metabolic syndrome and psychiatric disorders: a population-based study. Braz J Psychiatry. 2019;41:38–43. doi:10.1590/1516-4446-2017-2328
   PubMedGoogle Scholar
• Teixeira PJR, Rocha FL. The prevalence of metabolic syndrome among psychiatric inpatients in Brazil. Rev Bras Psiquiatr. 2007;29:330–336. doi:10.1590/S1516-44462007000400007
   PubMed Web of Science ®Google Scholar
• Saloojee S, Burns JK, Motala AA. Metabolic syndrome in South African patients with severe mental illness: prevalence and associated risk factors. PLoS One. 2016;11:e0149209. doi:10.1371/journal.pone.0149209
   PubMedGoogle Scholar
• Mousa FA, Dessoki HH, El Kateb SM, Ezzat AA, Soltan MR. Metabolic syndrome in psychiatric patients (comparative study). Egypt J Psychiatry. 2017;38:179–191. doi:10.4103/ejpsy.ejpsy_24_17
   Google Scholar
• Sweileh WM, Zyoud SH, Dalal SA, Ibwini S, Sawalha AF, Ali I. Prevalence of metabolic syndrome among patients with schizophrenia in Palestine. BMC Psychiatry. 2012;12:235. doi:10.1186/1471-244X-12-235
   PubMedGoogle Scholar
• Çankaya PK, Tiryaki A, Arslan FC, Çankaya S. Comparison of the prevalence of metabolic syndrome in patients with schizophrenia and bipolar disorder: a cross-sectional study from Black Sea region. Am J Psychiatry. 2018;19:346–354.
   Google Scholar
• Hussain T, Margoob MA, Shoib S, Shafat M, Chandel RK. Prevalence of metabolic syndrome among psychiatric inpatients: a hospital based study from Kashmir. J Clin Diagn Res. 2017;11:5–8.
   Google Scholar
• John AP, Koloth R, Dragovic M, Lim SC. Prevalence of metabolic syndrome among Australians with severe mental illness. Med J Aust. 2009;190:176–179. doi:10.5694/j.1326-5377.2009.tb02342.x
   PubMed Web of Science ®Google Scholar
• Maaroganye K, Mohapi M, Krüger C, Rheeder P. The prevalence of metabolic syndrome and its associated factors in long-term patients in a specialist psychiatric hospital in South Africa. Afr J Psychiatry. 2013;19:16.
   Google Scholar
• Ventriglio A, Baldessarini RJ, Vitrani G, et al. Metabolic syndrome in psychotic disorder patients treated with oral and long-acting injected antipsychotics. Front Psychiatry. 2019;9:744. doi:10.3389/fpsyt.2018.00744
   PubMed Web of Science ®Google Scholar
• Hatata H,El-Gohary, G., Abd-Elsalam, M., Elokda, E. Risk of metabolic syndrome among Egyptian patients with schizophrenia. Curr Psychiatr. 2009;16:85–95.
   Google Scholar
• Tran A, Gelaye B, Girma B, et al. Prevalence of metabolic syndrome among working adults in Ethiopia. Int J Hypertens. 2011;2011.
   Google Scholar
• Tadewos A, Addis Z, Ambachew H, Banerjee S. Prevalence of dyslipidemia among HIV-infected patients using first-line highly active antiretroviral therapy in Southern Ethiopia: a cross-sectional comparative group study. AIDS Res Ther. 2012;9:31. doi:10.1186/1742-6405-9-31
   PubMedGoogle Scholar
• Woyesa SB, Hirigo AT, Wube TB. Hyperuricemia and metabolic syndrome in type II diabetes mellitus patients at Hawassa university comprehensive specialized hospital, South West Ethiopia. BMC Endocr Disord. 2017;17:76. doi:10.1186/s12902-017-0226-y
   PubMedGoogle Scholar
• Sirdah MM, Al Laham NA, Abu Ghali AS. Prevalence of metabolic syndrome and associated socioeconomic and demographic factors among Palestinian adults (20–65 years) at the Gaza strip. Diabetes Metab Syndr. 2011;5:93–97. doi:10.1016/j.dsx.2012.02.024
   PubMedGoogle Scholar
• Al-Daghri NM, Alkharfy KM, Al-Attas OS, et al. Gender dependent associations between socioeconomic status andmetabolic syndrome: a cross-sectional study in the adult Saudi population. BMC Cardiovasc Disord. 2014;14:51.
   PubMedGoogle Scholar
• Rguibi M, Belahsen R. Overweight and obesity among urban Sahraoui women of South Morocco. Ethn Dis. 2004;14:542–547.
   PubMedGoogle Scholar